Latest filing published 22 Jun 2026 for Akebia Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Leanne M. Zumwalt: trading record in brief
Leanne M. Zumwalt, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Davita Inc., Advisory Board Co and Akebia Therapeutics, Inc. The record holds 110 filings, for trades running from 30 May 2007 to 17 June 2026.
The open-market record consists of 39 sales worth €13.2M, with no purchase. Outside the open market, there are 31 share grants and 37 option exercises.
The newest entry dates from 22 June 2026: a share grant, in Akebia Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leanne M. Zumwalt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,700 sharesCommon StockSEC:0001204946-26-000001:0
- 35,700 shares0Common StockSEC:0001562180-25-004724:0
- 30,000 shares0Common StockSEC:0001562180-24-004904:0
- 30,000 shares0Common StockSEC:0001562180-23-004960:0
- 13,700 shares0Common StockSEC:0001562180-22-004980:0
- 26,459 shares@ US$75.4233.2% of flowCommon StockSEC:0000927066-20-000198:0
- 24,190 shares@ US$90.1436.3% of flowCommon StockSEC:0000927066-20-000198:1
- 10,464 shares@ US$65.4811.4% of flowCommon StockSEC:0000927066-20-000198:2
- 8,961 shares@ US$90.1413.4% of flowCommon StockSEC:0000927066-20-000198:3
- 2,435 shares@ US$87.733.6% of flowCommon StockSEC:0000927066-20-000198:4
- 1,337 shares@ US$88.572.0% of flowCommon StockSEC:0000927066-20-000198:5
- 146 shares@ US$79.250.2% of flowCommon StockSEC:0000927066-20-000107:1
- 307 shares0Common StockSEC:0000927066-20-000107:0
- 1,646 shares0Common StockSEC:0000927066-20-000054:0
- 673 shares@ US$43.420.5% of flowCommon StockSEC:0000927066-19-000105:0
- 9,956 shares0Common StockSEC:0000927066-19-000094:0
- 710 shares@ US$66.910.4% of flowCommon StockSEC:0000927066-18-000124:0
- 848 shares@ US$66.830.4% of flowCommon StockSEC:0000927066-18-000110:0
- 373 shares@ US$69.450.2% of flowCommon StockSEC:0000927066-18-000059:0
- 5,200 shares@ US$58.942.3% of flowCommon StockSEC:0000927066-18-000036:0
- 4,414 shares@ US$69.452.3% of flowCommon StockSEC:0000927066-18-000036:1
- 5,400 shares@ US$55.342.4% of flowCommon StockSEC:0000927066-17-000094:0
- 4,451 shares@ US$67.142.4% of flowCommon StockSEC:0000927066-17-000094:1
- 949 shares@ US$68.190.5% of flowCommon StockSEC:0000927066-17-000094:2
- 4,423 sharesCommon StockSEC:0001209191-17-062125:0
25 of 110 declarations
